HomeInsightsStock Comparison

Hikal Ltd vs Samrat Pharmachem Ltd Stock Comparison

Hikal Ltd vs Samrat Pharmachem Ltd Stock Comparison

Last Updated on: Jul 04, 2025

Key Highlights

  • The Latest Trading Price of Hikal Ltd is ₹ 345.6 as of 04 Jul 11:59.
  • The P/E Ratio of Hikal Ltd changed from 10.2 on March 2020 to 47 on March 2024 . This represents a CAGR of 35.74% over 5 yearsThe P/E Ratio of Samrat Pharmachem Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Hikal Ltd changed from ₹ 863.11 crore on March 2020 to ₹ 3265 crore on March 2024 . This represents a CAGR of 30.49% over 5 yearsThe Market Cap of Samrat Pharmachem Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Hikal Ltd for the Mar '25 is ₹ 552.9 crore as compare to the Dec '24 revenue of ₹ 451.3 crore. This represent the growth of 22.51% The revenue of Samrat Pharmachem Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Hikal Ltd for the Mar '25 is ₹ 123.9 crore as compare to the Dec '24 ebitda of ₹ 75.7 crore. This represent the growth of 63.67% The ebitda of Samrat Pharmachem Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Hikal Ltd changed from ₹ 6.9 crore to ₹ 50.2 crore over 8 quarters. This represents a CAGR of 169.73% The net profit of Samrat Pharmachem Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Hikal Ltd changed from 17.52 % on March 2020 to 21.29 % on March 2024 . This represents a CAGR of 3.97% over 5 yearsThe Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 14.31 % on March 2024 . This represents a CAGR of 99.58% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Hikal Ltd

  • Hikal Limited, incorporated on July 8, 1988, has emerged as one of the preferred partners for global companies in segments such as pharmaceuticals, crop protection, animal health, biocides, and specialty chemicals.
  • The Company is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Company has 5 manufacturing facilities across three states in India.
  • It supply products to customers across the globe in the US, Japan, Europe, Canada, South East Asia, LATAM, India and RoW. Apart from this, it specialize in manufacturing APIs and intermediates in pharmaceutical division.
  • Within pharmaceutical division, it offer human health and animal health products. Hikal commenced its first project in 1991 at its first greenfield site at M.

About Samrat Pharmachem Ltd

  • Samrat Pharmachem Limited was incorporated on June 16, 1992.
  • The Company's principal activities are manufacturing and selling chemicals. The Company floated a new 100% subsidiary company during the year 2003-04 named as Samrat Remedies Limited to carry on activities of Manufacturing of Pharmaceutical Bulk Drugs & Chemicals.

Hikal Ltd News Hub

News

Hikal clears ANVISA GMP audit at Bengaluru API unit

The audit, which covered multiple active pharmaceutical ingredients (APIs), was conducted ...

Read more

17 Jun 2025 11:35

News

Board of Hikal approves change in directorate

The Board of Hikal at its meeting held on 14 May 2025 has approved redesignation of Sameer...

Read more

14 May 2025 16:06

News

Board of Hikal recommends Final Dividend

Hikal announced that the Board of Directors of the Company at its meeting held on 14 May 2...

Read more

14 May 2025 14:46

News

Hikal announces board meeting date

Hikal will hold a meeting of the Board of Directors of the Company on 14 May 2025. Powered...

Read more

08 May 2025 11:07

News

Hikal to convene board meeting

Hikal will hold a meeting of the Board of Directors of the Company on 14 May 2025. Powered...

Read more

07 May 2025 11:08

News

Board of Hikal recommends Interim Dividend

Hikal announced that the Board of Directors of the Company at its meeting held on 04 Febru...

Read more

04 Feb 2025 15:03

Samrat Pharmachem Ltd News Hub

News

Samrat Pharmachem to convene board meeting

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 13 Augus...

Read more

24 Jun 2025 09:54

News

Samrat Pharmachem AGM scheduled

Samrat Pharmachem announced that the 33th Annual General Meeting(AGM) of the company will ...

Read more

07 Jun 2025 17:20

News

Board of Samrat Pharmachem recommends final dividend

Samrat Pharmachem announced that the Board of Directors of the Company at its meeting held...

Read more

31 May 2025 12:04

News

Samrat Pharmachem to table results

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 30 May 2...

Read more

27 Mar 2025 09:23

News

Samrat Pharmachem to declare Quarterly Result

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 Febru...

Read more

31 Dec 2024 19:58

News

Samrat Pharmachem announces board meeting date

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 Novem...

Read more

28 Sep 2024 10:13

SWOT Analysis Of Hikal Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Hikal Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Samrat Pharmachem Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Hikal Ltd and Samrat Pharmachem Ltd

Which company has a larger market capitalization, Hikal Ltd or Samrat Pharmachem Ltd?

Market cap of Hikal Ltd is 4,283 Cr while Market cap of Samrat Pharmachem Ltd is 108 Cr

What are the key factors driving the stock performance of Hikal Ltd and Samrat Pharmachem Ltd?

The stock performance of Hikal Ltd and Samrat Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Hikal Ltd and Samrat Pharmachem Ltd?

As of July 4, 2025, the Hikal Ltd stock price is INR ₹347.4. On the other hand, Samrat Pharmachem Ltd stock price is INR ₹349.95.

How do dividend payouts of Hikal Ltd and Samrat Pharmachem Ltd compare?

To compare the dividend payouts of Hikal Ltd and Samrat Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions